significant migration inhibition with ef ( p less than 0.01 ) was seen with lymphocytes taken from 7/13 ( 54 % ) women with mild and/or moderate dysplasia , from 22/47 ( 47 % ) women with severe dysplasia and/or carcinoma in situ , from 6/10 ( 60 % ) women with invasive cervical carcinoma and from 3/20 ( 15 % ) women with benign gynaecological conditions .
C0334048
severe dysplasia
C0007099
carcinoma in situ